세계의 생체 보철 시장 보고서(2025년)
Bioprosthetics Global Market Report 2025
상품코드 : 1855807
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,666,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,635,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,605,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

생체 보철 시장 규모는 최근 몇 년 동안 강력하게 성장하고 있습니다. 2024년 57억 2,000만 달러로 평가되었고, 2025년에는 62억 7,000만 달러에 달하고, CAGR 9.7%로 성장할 전망입니다. 실적기간의 성장은 심혈관질환의 유병률 상승, 저침습 수술 수요 증가, 노인 인구 증가, 헬스케어 인프라 확대, 조직 기반 임플란트 채택 확대 등에 지지되고 있습니다.

생체 보철 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.3%로 89억 5,000만 달러로 성장할 전망입니다. 개인화된 치료 솔루션에 대한 선호도 증가, 신흥 국가의 건강 관리 지출 증가, 의료 관광 확대, 고급 수술 시설의 광범위한 가용성, 환자 중심 케어에 대한 관심 증가 등이 예측 기간의 성장을 이끌 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 밸브 설계의 기술적 진보, 조직 보존법의 혁신, 저침습 이식 기술의 발전, 생체 적합 재료의 개발, 재생 의료의 진보 등을 들 수 있습니다.

심혈관 질환의 유병률 증가는 앞으로 수년간 생체 보철 시장의 확대를 촉진할 것으로 예측됩니다. 심혈관 질환은 관상동맥 질환, 심부전, 부정맥, 선천성 심장 질환, 뇌졸중과 같은 뇌혈관 질환 등 심장 및 혈관에 영향을 미치는 다양한 질환을 포함합니다. 심혈관 질환 증가는 비만, 고혈압, 높은 콜레스테롤 수치의 원인이 되는 포화 지방산, 염분, 당분이 많은 식품의 섭취 등 식생활의 혼란이 원인이 되고 있습니다. 생체 보철은 손상된 심장 판막과 혈관을 생물학적으로 양립 가능한 임플란트로 대체하여 심장 기능을 개선하고 합병증의 위험을 줄임으로써 이러한 질병의 치료에 중요한 역할을 수행합니다. 예를 들어 미국 심장협회는 2024년 1월 심혈관 관련 사망자 수가 2022년 92만 8,741명에서 2023년에는 93만 1,578명으로 미세 증가했다고 보고했습니다. 이러한 심혈관 질환의 이환율의 상승은 생체 보철 시장의 성장을 가속하는 중요한 요인입니다.

생체 보철 시장의 주요 기업은 첨단 조직 기술 개발에 주력하고 있습니다. 이 기술은 석회화를 억제하고 장기적인 기능성을 향상시키는 생체 보철 재료의 특수 치료를 포함합니다. 예를 들어, 2022년 9월 미국 의료기기 제조업체인 에드워즈 생명과학은 SAPIEN 3 Ultra RESILIA 밸브의 FDA 승인을 받았습니다. 이 밸브는 내구성을 높이기 위해 항 석회화 기술로 처리 된 소심막 조직을 포함한 RESILIA 조직 기술을 사용합니다. SAPIEN 3 Ultra RESILIA 밸브는 이식을 단순화하고 절차의 정확성을 향상시키기 위해 설계된 얇은 배달 시스템을 특징으로 합니다. 또한 미국에서 사용할 수 있는 유일한 경피적 심장판막으로, 사용의 용이성과 최장 5년간 구조적 열화로부터 해방될 가능성을 제공하여 임상적 이익이 확대될 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Bioprosthetics is a field of biomedical science focused on developing implants or devices made from biological materials, sometimes combined with synthetic components, to replace or support damaged or missing tissues in the body. These materials are designed to replicate the structure and function of natural tissue, ensuring compatibility with the body, lowering the risk of immune rejection, and maintaining durability and long-term performance.

The primary types of bioprosthetics are allograft, xenograft, and autograft. An allograft is a transplant of tissue or an organ taken from a donor of the same species who is genetically different from the recipient. Bioprosthetics are applied in areas such as cardiovascular care, orthopedics, wound healing, and other fields, and are utilized by end users including hospitals, specialty centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The bioprosthetics market research report is one of a series of new reports from The Business Research Company that provides bioprosthetics market statistics, including the bioprosthetics industry global market size, regional shares, competitors with the bioprosthetics market share, detailed bioprosthetics market segments, market trends, and opportunities, and any further data you may need to thrive in the bioprosthetics industry. This bioprosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioprosthetics market size has grown strongly in recent years. It will grow from $5.72 billion in 2024 to $6.27 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. Growth in the historic period was supported by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive surgeries, growth in the geriatric population, expansion of healthcare infrastructure, and greater adoption of tissue-based implants.

The bioprosthetics market size is expected to see strong growth in the next few years. It will grow to $8.95 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. Growth in the forecast period is expected to be driven by a stronger preference for personalized treatment solutions, higher healthcare spending in emerging economies, expansion of medical tourism, wider availability of advanced surgical facilities, and an increasing focus on patient-centered care. Key trends anticipated for the forecast period include technological progress in valve design, innovations in tissue preservation methods, advancements in minimally invasive implantation techniques, the development of biocompatible materials, and progress in regenerative medicine.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the bioprosthetics market in the coming years. Cardiovascular diseases encompass a range of disorders that affect the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, congenital heart defects, and cerebrovascular diseases such as stroke. The rise in cardiovascular conditions is partly attributed to poor dietary habits, including the consumption of foods high in saturated fats, salt, and sugar, which contribute to obesity, hypertension, and high cholesterol levels. Bioprosthetics play a crucial role in treating these conditions by replacing damaged heart valves or blood vessels with biologically compatible implants, thereby improving heart function and reducing the risk of complications. For example, the American Heart Association reported in January 2024 that cardiovascular-related deaths increased slightly to 931,578 in 2023, up from 928,741 in 2022. This rising incidence of cardiovascular diseases is a key factor driving the growth of the bioprosthetics market.

Key companies in the bioprosthetics market are focusing on the development of advanced tissue technologies. This technology involves specialized treatments of bioprosthetic materials to reduce calcification and improve their long-term functionality. For instance, in September 2022, Edwards Lifesciences Corporation, a U.S.-based medical device company, received FDA approval for the SAPIEN 3 Ultra RESILIA valve. This valve uses RESILIA tissue technology, which involves bovine pericardial tissue treated with anti-calcification technology to extend durability. The SAPIEN 3 Ultra RESILIA valve features a low-profile delivery system designed to simplify implantation and improve procedural precision. It is also the only dry storage transcatheter heart valve available in the U.S., offering ease of use and the potential to provide freedom from structural valve deterioration for up to five years, with the possibility of extended clinical benefits.

In July 2024, Edwards Lifesciences Corporation further expanded its structural heart portfolio by acquiring Innovalve Bio Medical Ltd., an Israel-based company specializing in bioprosthetics. The terms of the acquisition were not disclosed, but the deal is expected to accelerate product development, enhance clinical capabilities, and increase patient access to minimally invasive heart valve therapies, particularly in the field of transcatheter aortic valve replacement (TAVR).

Major players in the bioprosthetics market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd., LivaNova PLC, Artivion Inc., LifeNet Health Inc., TTK Healthcare Limited, Corcym S.r.l., Biosensors International Group Ltd., Braile Biomedica, Xeltis NV, Peijia Medical Technology Co. Ltd., Labcor Laboratorios Ltda., Colibri Heart Valve LLC, Autotissue Berlin GmbH, Humacyte Inc., Bioprosthetics Inc., and Shijiazhuang Perfect Prosthetic Manufacture Co. Ltd.

North America was the largest region in the bioprosthetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bioprosthetics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioprosthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprosthetics market consists of revenues earned by entities by providing services such as custom implant design, biocompatibility testing, 3d modeling, and clinical research. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprosthetics market also includes sales of vascular grafts, cartilage repair scaffolds, bone grafts, dermal matrices, and biologic meshes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioprosthetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioprosthetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioprosthetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioprosthetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Bioprosthetics Market Characteristics

3. Bioprosthetics Market Trends And Strategies

4. Bioprosthetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bioprosthetics Growth Analysis And Strategic Analysis Framework

6. Bioprosthetics Market Segmentation

7. Bioprosthetics Market Regional And Country Analysis

8. Asia-Pacific Bioprosthetics Market

9. China Bioprosthetics Market

10. India Bioprosthetics Market

11. Japan Bioprosthetics Market

12. Australia Bioprosthetics Market

13. Indonesia Bioprosthetics Market

14. South Korea Bioprosthetics Market

15. Western Europe Bioprosthetics Market

16. UK Bioprosthetics Market

17. Germany Bioprosthetics Market

18. France Bioprosthetics Market

19. Italy Bioprosthetics Market

20. Spain Bioprosthetics Market

21. Eastern Europe Bioprosthetics Market

22. Russia Bioprosthetics Market

23. North America Bioprosthetics Market

24. USA Bioprosthetics Market

25. Canada Bioprosthetics Market

26. South America Bioprosthetics Market

27. Brazil Bioprosthetics Market

28. Middle East Bioprosthetics Market

29. Africa Bioprosthetics Market

30. Bioprosthetics Market Competitive Landscape And Company Profiles

31. Bioprosthetics Market Other Major And Innovative Companies

32. Global Bioprosthetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioprosthetics Market

34. Recent Developments In The Bioprosthetics Market

35. Bioprosthetics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기